FDA Approved: CUROSURF — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

FDA approved a supplemental labeling application for Curosurf (poractant alfa) from Chiesi USA, Inc., resulting in updated product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome of the Newborn

Drugs mentioned

• Curosurf (poractant alfa)

Snippet

SUPPL AP for CUROSURF (PORACTANT ALFA)